Article

The effect of access restrictions on the vintage of drugs used by Medicaid enrollees.

Graduate School of Business, Columbia University, New York, NY 10027, USA.
The American journal of managed care (Impact Factor: 2.17). 02/2005; 11 Spec No:SP7-13.
Source: PubMed

ABSTRACT To examine the extent to which recent Medicaid drug access restrictions, such as preferred drug lists (PDLs), may affect the vintage (or time since Food and Drug Administration approval) of 6 types of drugs used by Medicaid beneficiaries.
Retrospective claims database analysis using National Drug Code pharmacy claims data.
A regression model was developed to analyze the effect that Medicaid access restrictions had on the vintage of medications prescribed in 6 different therapeutic categories. A "difference in differences" approach was used to compare the change in vintage of medications prescribed in Medicaid versus non-Medicaid patients between the January-June 2001 and July-December 2003 study periods.
The results of the regression model showed that PDLs increased the age of Medicaid prescriptions by less than 1 year for drugs in 5 of the 6 therapeutic classes analyzed. In the case of pain management medications, the increase was more than 1.2 years.
The results of the regression model suggest that Medicaid drug access restriction programs (e.g., PDLs) have resulted in an increase in the age of drugs prescribed for Medicaid beneficiaries versus non-Medicaid patients. Since previous research has suggested a clinical and economic advantage to utilizing newer versus older drugs, further research should be conducted to explore how these medication restriction policies may unduly affect Medicaid beneficiaries compared with privately insured patients.

0 Followers
 · 
79 Views

Full-text (3 Sources)

Download
53 Downloads
Available from
May 31, 2014